| 注册
首页|期刊导航|中国健康心理学杂志|米氮平合并认知行为疗法治疗躯体形式障碍的疗效

米氮平合并认知行为疗法治疗躯体形式障碍的疗效

程毅

中国健康心理学杂志2016,Vol.24Issue(11):1612-1613,1614,3.
中国健康心理学杂志2016,Vol.24Issue(11):1612-1613,1614,3.DOI:10.13342/j.cnki.cjhp.2016.11.004

米氮平合并认知行为疗法治疗躯体形式障碍的疗效

The Efficacy of Mirtazapine Combined with Cognitive Behavior Therapy in Somatoform Disorder

程毅1

作者信息

  • 1. 中国.辽宁省沈阳市红十字会医院心理科 110013
  • 折叠

摘要

Abstract

Objective :To explore the clinical efficacy of cognitive behavior therapy (CBT )combined with mirtazapine in the treatment of somatoform disorder .Methods :68 patients met the criteria of somatoform disorder in CCMD - 3 were randomly divided into study group treated with mirtazapine combined with CBT and control group treated with mirtazapine monotherapy for 16 weeks ,The efficacy was assessed with symptom checklist - 90(SCL - 90) .Results :After 16 weeks treatment ,the scores of somatization ,depression ,anxiety ,phobia factors in the study group were sig‐nificantly lower than those in the control group(P < 0 .05) .The effective rate in study group was significantly higher than that in control group at the end of the treatment (85 .29% vs .61 .76% ;χ2 = 4 .836 ,P < 0 .05) .Conclusion :Mirtaza‐pine combined with CBT is better than mirtazapine monotherapy in the treatment for somatoform disorder .

关键词

米氮平/认知行为疗法/躯体形式障碍/疗效

Key words

Mirtazapine/Cognitive behavior therapy/Somatoform disorder/Clinical efficacy

分类

医药卫生

引用本文复制引用

程毅..米氮平合并认知行为疗法治疗躯体形式障碍的疗效[J].中国健康心理学杂志,2016,24(11):1612-1613,1614,3.

中国健康心理学杂志

OACSTPCD

2096-4811

访问量0
|
下载量0
段落导航相关论文